Product Images Drospirenone And Ethinyl Estradiol

This appears to be a table showing the ranges of blood clot incidents for non-pregnant individuals who are or are not using contraceptives. The table also provides information for blood clot incidents during pregnancy and postpartum periods. The data is represented in the form of numbers of blood clot incidents per 10,000 women years (WY). The text also mentions a model assumption for pregnancy duration and the rate of blood clot incidents based on it.*

This text appears to be a list of various studies and their hazard, rate or odds ratios. The studies include Ingenix, EURAS, LASS, FDA-funded study, Danish, Danish re-analysis, MEGA study, German case-control and PharMetrics. Some studies are cohort studies, retrospective cohort studies or case-control studies. The text also mentions non-fatal idiopathic cases. There are some numeric values listed as 0.1 and 0.2 along with 10, but their significance is not clear without additional context.*

This text presents various ranges for non-pregnant and postpartum individuals, including those who use or do not use contraceptives. Additionally, it presents data on the number of women who experience blood clots out of 10,000 women years (WY) based on actual duration of pregnancies in reference studies, with a model assumption of nine months pregnancy duration resulting in a rate of 7 to 27 per 10,000 WY.*

Drospirenone/Ethinyl estradiol is a combination medication used primarily as a birth control pill to prevent pregnancy. It contains two female hormones, a synthetic progestin called drospirenone and a synthetic estrogen called ethinyl estradiol. This medication works by preventing ovulation (the release of an egg from an ovary) and by causing changes in cervical mucus and the lining of the uterus, making it more difficult for sperm to fertilize an egg or for a fertilized egg to attach to the uterus.*

This is a description of a medication called "Drospirenone and Ethinyl Estradiol Tablets, USP" which is contained in a blister pack. Each blister card contains 24 pink tablets with 3 mg drospirenone and 0.02 mg ethinyl estradiol and 4 white inert tablets. It should be kept out of reach of children and stored between 20°C to 25°C. The medication is available in a pack of 84 tablets divided into 3x28 tablet blister cards and requires a prescription.*